Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.
The Pharmacovigilance (PV) market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Pharmacovigilance (PV) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Pharmacovigilance (PV) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Pharmacovigilance (PV) market are:
Laboratory Corporation of America Holdings
ICON PLC
United BioSource Corporation
IT Clinical
Cognizant
BioClinica
Foresight Group International AG
Accenture
Capgemini
Wipro Limited
IBM
TAKE Solutions Ltd
PAREXEL International Corporation
ArisGlobal

Most important types of Pharmacovigilance (PV) products covered in this report are:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

Most widely used downstream fields of Pharmacovigilance (PV) market covered in this report are:
Hospitals
Pharmaceutical Companies
Other End Users

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026